Profile data is unavailable for this security.
About the company
Hims & Hers Health, Inc. is a consumer-first platform focused on providing personalized health and wellness experiences to consumers. The Company's digital platform enables access to treatments for a range of conditions, including those related to sexual health, hair loss, dermatology, mental health and primary care. It connects patients to licensed healthcare professionals who can prescribe medications when appropriate. The prescriptions are fulfilled online through licensed pharmacies on a subscription basis. Through the Hims & Hers mobile applications, consumers can access a range of educational programs, wellness content, community support, and other services that promote lifelong health and wellness. The Company's products include shampoo, conditioner, biotin gummies, anti-aging cream, vitamin c serum, acne cream and moisturizer. Its products are sold in tens of thousands of retail locations in the United States.
- Revenue in USD (TTM)526.92m
- Net income in USD-65.68m
- Incorporated2021
- Employees651.00
- LocationHims & Hers Health Inc2269 Chestnut St, #523SAN FRANCISCO 94123United StatesUSA
- Phone+1 (415) 851-0195
- Fax+1 (302) 655-5049
- Websitehttps://www.forhims.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Relay Therapeutics Inc | 1.38m | -290.51m | 1.89bn | 327.00 | -- | 1.99 | -- | 1,369.42 | -2.60 | -2.60 | 0.0123 | 7.85 | 0.0013 | -- | 0.2719 | 4,223.24 | -27.56 | -- | -28.76 | -- | -- | -- | -21,036.13 | -- | -- | -- | 0.00 | -- | -54.41 | -- | 20.16 | -- | -- | -- |
| Myriad Genetics, Inc. | 678.40m | -112.00m | 1.90bn | 2.60k | -- | 2.14 | -- | 2.80 | -1.39 | -1.39 | 8.42 | 10.91 | 0.5385 | 11.41 | 7.03 | 260,923.10 | -8.89 | -- | -10.29 | -- | 70.22 | -- | -16.51 | -- | 1.85 | -206.17 | 0.00 | -- | -1.77 | -- | -357.14 | -- | -- | -- |
| Krystal Biotech Inc | 0.00 | -139.98m | 1.92bn | 210.00 | -- | 3.68 | -- | -- | -5.50 | -5.50 | 0.00 | 20.27 | 0.00 | -- | -- | 0.00 | -23.63 | -17.34 | -24.77 | -18.06 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -101.20 | -- | 202.26 | -- |
| Supernus Pharmaceuticals Inc | 667.24m | 60.71m | 2.00bn | 612.00 | 35.13 | 2.25 | 13.58 | 2.99 | 1.04 | 1.04 | 11.12 | 16.33 | 0.3935 | 0.9828 | 4.24 | 1,090,258.00 | 3.58 | 7.27 | 5.08 | 9.11 | 86.93 | 90.40 | 9.10 | 18.11 | 0.9341 | -- | 0.312 | -- | 15.09 | 17.16 | 13.64 | -1.95 | -27.30 | -- |
| Amylyx Pharmaceuticals Inc | 22.23m | -198.38m | 2.02bn | 262.00 | -- | 5.91 | -- | 90.82 | -3.43 | -3.43 | 0.3802 | 5.12 | 0.0894 | -- | -- | 84,847.33 | -79.82 | -- | -91.62 | -- | 86.54 | -- | -892.38 | -- | 7.99 | -- | 0.00 | -- | 7,700.00 | -- | -125.60 | -- | -- | -- |
| Hims & Hers Health Inc | 526.92m | -65.68m | 2.09bn | 651.00 | -- | 6.71 | -- | 3.97 | -0.3214 | -0.3214 | 2.58 | 1.50 | 1.34 | 6.73 | 154.79 | 809,394.80 | -16.69 | -- | -19.91 | -- | 77.57 | -- | -12.46 | -- | 4.07 | -- | 0.00 | -- | 93.81 | -- | 38.99 | -- | -- | -- |
| Xenon Pharmaceuticals Inc | 9.43m | -124.94m | 2.11bn | 203.00 | -- | 2.90 | -- | 223.58 | -1.95 | -1.95 | 0.1515 | 11.53 | 0.0142 | -- | 5.03 | 46,472.91 | -18.91 | -21.60 | -19.45 | -23.05 | -- | -- | -1,328.95 | -462.39 | -- | -- | 0.00 | -- | -48.83 | 97.87 | -62.07 | -- | 55.83 | -- |
| Immunovant Inc | 0.00 | -198.70m | 2.11bn | 124.00 | -- | 5.05 | -- | -- | -1.65 | -1.65 | 0.00 | 3.21 | 0.00 | -- | -- | 0.00 | -39.76 | -- | -43.11 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -45.89 | -- | -- | -- |
| BridgeBio Pharma Inc | 77.65m | -481.18m | 2.16bn | 392.00 | -- | -- | -- | 27.87 | -3.26 | -3.26 | 0.5265 | -8.33 | 0.0949 | -- | -- | 198,081.60 | -59.25 | -64.11 | -71.02 | -78.45 | 95.58 | 95.39 | -624.17 | -1,037.16 | -- | -- | 3.69 | -- | 11.38 | -- | 14.46 | -- | 68.60 | -- |
| Provention Bio Inc | 2.80m | -106.12m | 2.18bn | 82.00 | -- | 14.39 | -- | 778.86 | -1.56 | -1.56 | 0.0408 | 1.66 | 0.0159 | -- | -- | 34,134.14 | -60.33 | -79.68 | -69.39 | -88.17 | -- | -- | -3,791.21 | -20,925.40 | -- | -- | 0.1386 | -- | -- | -- | -16.08 | -- | -- | -- |
| TG Therapeutics Inc | 2.78m | -198.34m | 2.18bn | 226.00 | -- | 37.28 | -- | 784.39 | -1.47 | -1.47 | 0.0206 | 0.4002 | 0.0097 | -- | 4.01 | 12,318.58 | -69.20 | -83.88 | -87.25 | -108.48 | 90.48 | -- | -7,124.10 | -11,804.33 | -- | -18.92 | 0.5484 | -- | -58.36 | 78.80 | 43.02 | -- | 44.40 | -- |
| AbCellera Biologics Inc | 485.43m | 158.52m | 2.19bn | 495.00 | 15.32 | 1.77 | 11.76 | 4.52 | 0.4973 | 0.4973 | 1.62 | 4.30 | 0.3395 | -- | 1.03 | 980,658.60 | 11.09 | -- | 12.10 | -- | -- | -- | 32.66 | -- | 8.65 | -- | 0.00 | -- | 29.38 | -- | 3.29 | -- | -- | -- |
| Ventyx Biosciences Inc | 0.00 | -90.98m | 2.25bn | 31.00 | -- | 5.86 | -- | -- | -1.79 | -1.79 | 0.00 | 6.77 | 0.00 | -- | -- | 0.00 | -31.97 | -- | -34.88 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -202.75 | -- | -- | -- |
| Revolution Medicines Inc | 35.38m | -248.71m | 2.27bn | 246.00 | -- | 2.82 | -- | 64.08 | -3.10 | -3.10 | 0.439 | 7.57 | 0.0457 | -- | 6.67 | 143,821.10 | -32.09 | -30.02 | -34.84 | -33.44 | -- | -- | -702.95 | -355.93 | -- | -- | 0.00 | -- | 20.38 | -- | -32.93 | -- | 47.01 | -- |
| Corcept Therapeutics Incorporated | 401.86m | 101.42m | 2.29bn | 299.00 | 24.28 | 5.55 | 22.44 | 5.71 | 0.8751 | 0.8751 | 3.47 | 3.83 | 0.798 | 0.9713 | 13.70 | 1,344,007.00 | 20.14 | 23.08 | 22.86 | 25.75 | 98.66 | 98.39 | 25.24 | 29.15 | 6.80 | -- | 0.00 | 0.00 | 9.80 | 20.34 | -9.86 | -8.98 | -0.288 | -- |
Data as of Mar 23 2023. Currency figures normalised to Hims & Hers Health Inc's reporting currency: US Dollar USD
20.23%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Dec 2022 | 11.03m | 5.53% |
| BlackRock Fund Advisorsas of 31 Dec 2022 | 8.00m | 4.01% |
| Marshall Wace LLPas of 31 Dec 2022 | 4.49m | 2.25% |
| Millennium Management LLCas of 31 Dec 2022 | 3.52m | 1.77% |
| Oaktree Capital Management LPas of 31 Dec 2022 | 3.27m | 1.64% |
| SSgA Funds Management, Inc.as of 31 Dec 2022 | 2.94m | 1.48% |
| Geode Capital Management LLCas of 31 Dec 2022 | 2.19m | 1.10% |
| Franklin Advisers, Inc.as of 31 Dec 2022 | 1.79m | 0.90% |
| Canada Pension Plan Investment Boardas of 31 Dec 2022 | 1.58m | 0.79% |
| Renaissance Technologies LLCas of 31 Dec 2022 | 1.51m | 0.76% |
More ▼
Data from 31 Dec 2022 - 31 Dec 2022Source: FactSet Research Systems Inc.
